Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer암에 대한 적극적인 치료를 받는 환자의 SARS-CoV-2 백신 접종 효능 개선에 대한 현재 전망Review Published on 2021-09-012022-09-12 Journal: European journal of cancer (Oxford, England : 1990 [Category] MERS, 진단, [키워드] accelerated anti-CD20 treatment appear ARNm Cancer coronavirus disease Coverage COVID-19 current death dependent on dose Double-dose effective Efficacy evaluated global pandemic haematological malignancy heterologous prime-boost Heterologous prime-boost vaccination higher risk humoral immune response immune stimulation Immunocompromised patient immunogenicity Impaired less mRNA vaccine Patient Patients with cancer Perspective repeated reported SARS-CoV-2 SARS-CoV-2 vaccination shown solid cancer the SARS-CoV-2 therapeutic third dose Treatment trials Tumours vaccination Vaccine [DOI] 10.1016/j.ejca.2021.06.008 PMC 바로가기 [Article Type] Review